Landscape of homologous recombination deficiency in gastric cancer and clinical implications for first-line chemotherapy.
Ichikawa, H., Aizawa, M., Kano, Y., Hanyu, T., Muneoka, Y., Hiroi, S., Ueki, H., Moro, K., Hirose, Y., Miura, K., Shimada, Y., Sakata, J., Yabusaki, H., Nakagawa, S., Kawasaki, T., Okuda, S., Wakai, T. Landscape of homologous recombination deficiency in gastric cancer and clinical implications for first-line chemotherapy. Gastric Cancer 27(6):1273-1286(2024).
Clinical application of targeted tumour sequencing tests for detecting ERBB2 amplification and optimizing anti-HER2 therapy in gastric cancer.
Ichikawa, H., Usui, K., Aizawa, M., Shimada, Y., Muneoka, Y., Kano, Y., Sugai, M., Moro, K., Hirose, Y., Miura, K., Sakata, J., Yabusaki, H., Nakagawa, S., Kawasaki, T., Umezu, H., Okuda, S., Wakai, T. Clinical application of targeted tumour sequencing tests for detecting ERBB2 amplification and optimizing anti-HER2 therapy in gastric cancer. BMC Cancer 24(1):719(2024).
.
Mucin phenotype and genetic alterations in non-V600E BRAF-mutated colorectal cancer.
Ozeki, H., Shimada, Y., Nakano, M., Kondo, S., Ohashi, R., Miwa, Y., Yamai, D., Matsumoto, A., Abe, K., Tajima, Y., Ichikawa, H., Sakata, J., Takii, Y., Sugai, M., Nagai, T., Ling, Y., Okuda, S., Wakai, T. Mucin phenotype and genetic alterations in non-V600E BRAF-mutated colorectal cancer. Hum. Pathol. 145:71-79(2024).
Clonal origin and genomic diversity in Lynch syndrome-associated endometrial cancer with multiple synchronous tumors: Identification of the pathogenicity of MLH1 p.L582H.
Takahashi, K., Yachida, N., Tamura, R., Adachi, S., Kondo, S., Abé, T., Umezu, H., Nyuzuki, H., Okuda, S., Nakaoka, H., Yoshihara, K. Clonal origin and genomic diversity in Lynch syndrome-associated endometrial cancer with multiple synchronous tumors: Identification of the pathogenicity of MLH1 p.L582H. Genes Chromosomes Cancer 63(3):e23231(2024).
BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis.
Abe, H., Kamimura, K., Okuda, S., Watanabe, Y., Inoue, J., Aoyagi, Y., Wakai, T., Kominami, R., Terai, S. BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis. Cancer Med. 12(14):15650‐15663 (2023).
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients.
Nagahashi, M., Ling, Y., Toshikawa, C., Hayashida, T., Kitagawa, Y., Futamura, M., Kuwayama, T., Nakamura, S., Yamauchi, H., Yamauchi, T., Kaneko, K., Kanbayashi, C., Sato, N., Tsuchida, J., Moro, K., Nakajima, M., Shimada, Y., Ichikawa, H., Lyle, S., Miyoshi, Y., Takabe, K., Okuda, S., Wakai, T. Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients. Breast Cancer 30(4):584-595(2023).
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients.
Nagahashi, M., Ling, Y., Toshikawa, C., Hayashida, T., Kitagawa, Y., Futamura, M., Kuwayama, T., Nakamura, S., Yamauchi, H., Yamauchi, T., Kaneko, K., Kanbayashi, C., Sato, N., Tsuchida, J., Moro, K., Nakajima, M., Shimada, Y., Ichikawa, H., Lyle, S., Miyoshi, Y., Takabe, K., Okuda, S., Wakai, T. Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients. SABCS2022, San Antonio (2022/12/6).
Gene panel testing detects important genetic alterations in ulcerative colitis-associated colorectal neoplasia.
Shimada, Y., Nakano, M., Mizuno, K. I., Yokoyama, J., Matsumoto, A., Tanaka, K., Oyanagi, H., Nakano, M., Hirose, Y., Ichikawa, H., Sakata, J., Kameyama, H., Takii, Y., Sugi, M., Ling, Y., Takeuchi, S., Okuda, S., Terai, S., Ajioka, Y., Wakai, T. Gene panel testing detects important genetic alterations in ulcerative colitis-associated colorectal neoplasia. Oncol. Lett. 24(6):442(2022).
Activin a Receptor Type 2A Mutation Affects the Tumor Biology of Microsatellite Instability-High Gastric Cancer.
Yuza, K., Nagahashi, M., Ichikawa, H., Hanyu, T., Nakajima, M., Shimada, Y., Ishikawa, T., Sakata, J., Takeuchi, S., Okuda, S., Matsuda, Y., Abe, M., Sakimura, K., Takabe, K., Wakai, T. Activin a Receptor Type 2A Mutation Affects the Tumor Biology of Microsatellite Instability-High Gastric Cancer. J. Gastrointest. Surg. 25(9):2231-2241(2021).
Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer.
Shimada, Y., Okuda, S., Watanabe, Y., Tajima, Y., Nagahashi, M., Ichikawa, H., Nakano, M., Sakata, J., Takii, Y., Kawasaki, T., Homma, K. I., Kamori, T., Oki, E., Ling, Y., Takeuchi, S., Wakai, T. Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer. J. Gastroenterol. 56(6):547-559(2021).